Prognostic value of breast cancer aromatase

Allan Lipton, Richard J. Santen, Steven J. Santner, Harold A. Harvey, Sherry I. Sanders, Yvonne L. Matthews

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

The estrogen receptor, progesterone receptor, and intratumoral aromatase content of 127 breast carcinomas were determined. Patients whose tumor contained either estrogen or progesterone receptors had a longer disease‐free interval, but no difference in survival was observed. Measurable aromatase activity was detected in 78 of 113 (69%) tumors. There was no relationship between aromatase activity and disease‐free interval or survival. Cancer 1992; 70:1951‐1955.

Original languageEnglish (US)
Pages (from-to)1951-1955
Number of pages5
JournalCancer
Volume70
Issue number7
DOIs
StatePublished - Oct 1 1992

Fingerprint

Aromatase
Progesterone Receptors
Breast Neoplasms
Estrogen Receptors
Neoplasms
Survival

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Lipton, Allan ; Santen, Richard J. ; Santner, Steven J. ; Harvey, Harold A. ; Sanders, Sherry I. ; Matthews, Yvonne L. / Prognostic value of breast cancer aromatase. In: Cancer. 1992 ; Vol. 70, No. 7. pp. 1951-1955.
@article{d704e5317e0348ff8b2a913200f92bc6,
title = "Prognostic value of breast cancer aromatase",
abstract = "The estrogen receptor, progesterone receptor, and intratumoral aromatase content of 127 breast carcinomas were determined. Patients whose tumor contained either estrogen or progesterone receptors had a longer disease‐free interval, but no difference in survival was observed. Measurable aromatase activity was detected in 78 of 113 (69{\%}) tumors. There was no relationship between aromatase activity and disease‐free interval or survival. Cancer 1992; 70:1951‐1955.",
author = "Allan Lipton and Santen, {Richard J.} and Santner, {Steven J.} and Harvey, {Harold A.} and Sanders, {Sherry I.} and Matthews, {Yvonne L.}",
year = "1992",
month = "10",
day = "1",
doi = "10.1002/1097-0142(19921001)70:7<1951::AID-CNCR2820700723>3.0.CO;2-#",
language = "English (US)",
volume = "70",
pages = "1951--1955",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

Prognostic value of breast cancer aromatase. / Lipton, Allan; Santen, Richard J.; Santner, Steven J.; Harvey, Harold A.; Sanders, Sherry I.; Matthews, Yvonne L.

In: Cancer, Vol. 70, No. 7, 01.10.1992, p. 1951-1955.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prognostic value of breast cancer aromatase

AU - Lipton, Allan

AU - Santen, Richard J.

AU - Santner, Steven J.

AU - Harvey, Harold A.

AU - Sanders, Sherry I.

AU - Matthews, Yvonne L.

PY - 1992/10/1

Y1 - 1992/10/1

N2 - The estrogen receptor, progesterone receptor, and intratumoral aromatase content of 127 breast carcinomas were determined. Patients whose tumor contained either estrogen or progesterone receptors had a longer disease‐free interval, but no difference in survival was observed. Measurable aromatase activity was detected in 78 of 113 (69%) tumors. There was no relationship between aromatase activity and disease‐free interval or survival. Cancer 1992; 70:1951‐1955.

AB - The estrogen receptor, progesterone receptor, and intratumoral aromatase content of 127 breast carcinomas were determined. Patients whose tumor contained either estrogen or progesterone receptors had a longer disease‐free interval, but no difference in survival was observed. Measurable aromatase activity was detected in 78 of 113 (69%) tumors. There was no relationship between aromatase activity and disease‐free interval or survival. Cancer 1992; 70:1951‐1955.

UR - http://www.scopus.com/inward/record.url?scp=0026746314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026746314&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19921001)70:7<1951::AID-CNCR2820700723>3.0.CO;2-#

DO - 10.1002/1097-0142(19921001)70:7<1951::AID-CNCR2820700723>3.0.CO;2-#

M3 - Article

C2 - 1525771

AN - SCOPUS:0026746314

VL - 70

SP - 1951

EP - 1955

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 7

ER -